S 2514 115th Congress Senate Commerce Civil actions and liability Competitiveness, trade promotion, trade deficits Federal-Indian relations Government liability Intellectual property Jurisdiction and venue Sovereignty, recognition, national governance and status

PACED Act

Introduced: March 7, 2018 Introduced by: Cotton, Tom Republican · Arkansas See on congress.gov

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Mar 7, 2018

Read twice and referred to the Committee on the Judiciary.

Mar 7, 2018

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

Preserving Access to Cost Effective Drugs Act or the PACED Act

This bill prohibits patent owners from asserting tribal sovereign immunity as a defense in certain proceedings before the U.S. Patent and Trademark Office, including patent validity challenge proceedings before the Patent Trial and Appeal Board (PTAB). The prohibition also applies to court actions and proceedings before the International Trade Commission.

Sovereign immunity for foreign states shall apply in the PTAB as it applies in federal court.

What's happening now March 7, 2018

Read twice and referred to the Committee on the Judiciary.

Bill text 1 version